EMA to review label extension for Eisai's Zonegran as epilepsy monotherapy
28 July 2011
Pial Ganguli
Please Login to read the full article.
28 July 2011
Pial Ganguli
Please Login to read the full article.
RELATED CONTENT
NEWS
- ARISTOTLE: changing thinking about BMS/Pfizer's Eliquis in anticoagulation?
- Positive Phase III data for LifeCycle's 'improved Prograf' despite higher drop-out
- Lyrica met goal in study of central neuropathic pain after spinal cord injury
- Upsher-Smith begins Phase III trial of intranasal midazolam for epilepsy seizure clusters
COMMENT
